Proceedings from the Second Annual Miami General Medical
Oncology Symposium — Part 11: Lung Cancer. Featuring perspectives
from Drs Hossein Borghaei, Leora Horn, Stephen V Liu and Gregory J
Riely.
Immune Checkpoint Inhibitors in Lung
Cancer
Immune Checkpoint Inhibitors in Locally Advanced and Small Cell
Lung Cancer — Dr Liu
Factors Affecting the Selection of First-Line Therapy for
Metastatic Non-Small Cell Lung Cancer (NSCLC); Role of PD-L1 in
Current Decision-Making — Dr Borghaei
Targeted Treatment of Lung Cancer
First-Line Treatment for Patients with Metastatic EGFR-Mutated
NSCLC and CNS Metastases — Dr Riely
Treatment of BRAF-, NTRK- and RET-Positive NSCLC — Dr Horn
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.